The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pneumonitis (ILD), acute and/or severe (may produce the ARDS pattern)
May cause an ARDS picture
Publications
Complications of Lung Transplantation: A Roentgenographic Perspective.
Chest. 2016;149(6):1535-45
Acute respiratory distress attributed to sirolimus in solid organ transplant recipients.
The American journal of emergency medicine. 2015;33(1):124.e1-4
Sirolimus-induced pneumonitis following liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2007;13(6):853-6
Acute sirolimus pulmonary toxicity in an infant heart transplant recipient: case report and literature review.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007;26(3):296-8
Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.
Clinical transplantation. 2005;19(5):698-703
Fatal interstitial pneumonitis associated with sirolimus therapy in a heart transplant recipient.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2004;23(6):780-2